Labetuzumab
Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC) .
Product Specifications
CAS Number
219649-07-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
145.1 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
